937369-77-2 Usage
General Description
5-phenylthiazole-2-carboxylic acid is a synthetic, organic compound characterized by the presence of the phenyl group and thiazole group, which is a ring structure containing one nitrogen atom and one sulfur atom. It also contains a carboxylic acid group, which contributes to its acidic properties. The properties of 5-phenylthiazole-2-carboxylic acid have made it a useful component in several chemical reactions. 5-phenylthiazole-2-carboxylic acid is a white crystal solid at room temperature with a molar mass of 237.29 g·mol?1. Extensive research is ongoing to explore its potential applications in fields like medicine and electrochemistry. Its potential toxicity or safety profile has not been thoroughly researched yet, thus it must be handled with care.
Check Digit Verification of cas no
The CAS Registry Mumber 937369-77-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,7,3,6 and 9 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 937369-77:
(8*9)+(7*3)+(6*7)+(5*3)+(4*6)+(3*9)+(2*7)+(1*7)=222
222 % 10 = 2
So 937369-77-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H7NO2S/c12-10(13)9-11-6-8(14-9)7-4-2-1-3-5-7/h1-6H,(H,12,13)
937369-77-2Relevant articles and documents
INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 30
-
Paragraph 00192; 00205, (2019/04/30)
The present disclosure relates to chemical entities useful as inhibitors of Ubiquitin Specific Peptidase 30 (USP30), pharmaceutical compositions comprising the chemical entities, and methods of using the chemical entities. The chemical entities as disclosed herein can be useful in the treatment of a disease, disorder, or condition involving mitochondrial dysfunction, including neurodegenerative diseases, motor neuron diseases, metabolic disorders, and cancers, among other ailments.
NOVEL COMPOUNDS
-
Page/Page column 104, (2014/10/03)
The present invention relates to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N- [3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides of general formula(I) as described and defined herein,to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease.
